Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Death_Metalon Jan 08, 2017 12:49pm
187 Views
Post# 25680529

RE:RE:RE:RE:Is this what we have been waiting for

RE:RE:RE:RE:Is this what we have been waiting for
LaserStock29 wrote: Just a thought

Our public offering was completed Nov 10 for 4.1m?  lets say 3.6 for conservative 

Lets guess on the high end

Burn = 400k = 9 months of runway

Nov-Dec-Jan-Feb-Mar-Apr-May-June-July 31  (Out of funds)

Nov-Dec-Jan-Feb-Mar-Apr-May-June-July  (Jan 3 low dose + 1 month then 6 more Feb??)

Nov-Dec-Jan-Feb-Mar-Apr-May-June-July  (3 Low dose 5 months... 6 high.. 3-4 months in)

Nov-Dec-Jan-Feb-Mar-Apr-May-June-July (3 months at $2 or $4 uplist) (When you'd want to fundraise im assuming----that whole maximize shareholder value thing 

End of Q2 is the announcement of Lung and GMB phase 1b?

well.... if im even close to how this ball game is to be played.. then there isn't any room for delaying anything.

Just glad we have a super strong community of doctors to refer patients and the best hospital..:-)




Makes you wonder why Mr. White only did $4 mil. I always thought it was that amount to only get the first 3 patients treated. So after the first 3, there must be much bigger plans; JV, big financing, Frost...?

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities